Spectral AI (MDAI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
Annual meeting scheduled for May 29, 2026, with both in-person and virtual attendance options.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online and by request.
Voting matters and shareholder proposals
Election of five directors to serve until the next annual meeting or until successors are elected and qualified.
Ratification of Forvis Mazars, LLP as independent registered public accounting firm for fiscal year 2026.
Authorization to reserve and issue shares of common stock for sale to Hudson Bay Master Fund Ltd. under a Securities Purchase Agreement dated October 24, 2025.
Provision to transact any other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all three main proposals.
Director nominees include Dr. J. Michael DiMaio, Richard Cotton, Martin Mellish, Deepak Sadagopan, and Marion Snyder.
Latest events from Spectral AI
- Shareholders will vote on director elections, auditor ratification, and a significant share issuance.MDAI
Proxy filing16 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and a significant share issuance.MDAI
Proxy filing6 Apr 2026 - 2025 net loss narrowed, cash rose to $15.4M, and 2026 revenue is forecast at $18.5M.MDAI
Q4 202524 Mar 2026 - Q2 revenue up 76% year-over-year; DeepView commercialization and funding risks persist.MDAI
Q2 20241 Feb 2026 - AI-driven wound care system nears FDA submission, with UK pilots and strong funding support.MDAI
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Q3 revenue up 138% to $8.2M, margins improved, and FDA submission and spin-off plans advance.MDAI
Q3 202416 Jan 2026 - FY 2024 R&D revenue hit $29.6M as DeepView excelled in trials and FDA submission nears.MDAI
Q4 202424 Dec 2025 - AI diagnostics firm seeks up to $50M via Nasdaq offering to fund R&D and repay debt.MDAI
Registration Filing16 Dec 2025 - AI wound diagnostics firm registers 1M shares for resale; no proceeds to company, high risk profile.MDAI
Registration Filing16 Dec 2025